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Abstract	  
	  Aberrant	   neural	   crest	   (NC)	   development	   is	   at	   the	   origin	   of	  many	   congenital	   diseases.	  Given	  the	  limitations	  in	  human	  NC	  cell	  isolation	  and	  expansion,	  the	  development	  of	  new	  strategies	   for	   NC	   generation	   is	   crucial.	   In	   this	   issue,	   Kim	   et	   al.	   report	   the	   direct	  reprogramming	  of	  postnatal	  fibroblasts	  into	  multipotent	  NC	  cells.	  	  	  
Main	  text	  Neural	  crest	  (NC)	  cells	  occupy	  a	  unique	  position	  among	  stem	  cell	  populations	  found	  in	  the	   embryo.	   First,	   the	   NC	   innovation	   was	   a	   crucial	   event	   in	   vertebrate	   evolution	   by	  making	  possible	  the	  development	  of	  paired	  sense	  organs	  and,	  with	  the	  development	  of	  NC-­‐derived	  jaws,	  the	  transition	  to	  a	  more	  predatory	  life	  style.	  Second,	  the	  NC	  has	  one	  of	  the	  broadest	  differentiation	  potentials	   in	  vivo,	  surpassed	  only	  by	  the	  inner	  cell	  mass	  of	  the	   blastocyst	   (Bronner	   and	   LeDouarin,	   2012).	   As	   a	   consequence,	   anomalous	   NC	  development	   is	   at	   the	   onset	   of	   many	   congenital	   diseases	   including	   craniofacial,	  cardiovascular	  and	  bowel	  syndromes	  (Takahashi	  et	  al.,	  2013).	  Aberrant	  NC	  biology	  has	  also	   been	   associated	   with	   cancer	   originating	   from	   NC-­‐derived	   tissues,	   such	   as	  melanoma,	  the	  most	  aggressive	  skin	  cancer	  (Shakhova	  et	  al.,	  2012).	  Understanding	  how	  NC	  cells	  develop	  and	  generate	  their	  distinct	  progeny	  is	  thus	  highly	  relevant.	  In	  this	  issue,	  Kim	   and	   colleagues	   report	   the	   direct	   reprogramming	   of	   postnatal	   fibroblasts	   into	  induced	   neural	   crest	   cells	   (iNCCs).	   This	   approach	   constitutes	   an	   excellent	   platform	   to	  investigate	  NC	  biology	  in	  development	  and	  disease	  (Kim	  et	  al.,	  2014).	  The	  NC	   is	  a	   transient	  stem	  cell	  population	   that	  emerges	   from	  the	  dorsal	  margin	  of	   the	  neural	   plate	   in	   vertebrate	   embryos.	   During	   neural	   tube	   closure,	   NC	   cells	   undergo	   an	  epithelial	   to	   mesenchymal	   transition	   (EMT)	   and migrate	   extensively	   to	   populate	  different	  parts	  of	   the	  embryo.	   In	   their	   target	  structures,	   they	  give	  rise	   to	  a	  plethora	  of	  cell	  types	  and	  tissues,	  such	  as	  the	  ectomesenchyme	  of	  the	  craniofacial	  elements,	  glia	  and	  neurons	  of	   the	  peripheral	  nervous	  system	  (PNS),	  melanocytes	   in	   the	  skin,	  and	  smooth	  muscle	  cells	  of	  the	  outflow	  track	  of	  the	  heart.	  	  The	   existence	   of	   cells	   with	   NC	   potential	   is	   not	   restricted	   to	   early	   embryonic	  development	   since	  NC-­‐like	   cells	   have	  been	   identified	   in	  NC-­‐derived	   tissues	  during	   the	  fetal	   period	   and	   adulthood	   of	   various	   vertebrate	   species,	   including	   human.	  Moreover,	  NC-­‐like	  cells	  have	  been	  isolated	  from	  many	  sources,	  such	  as	  skin,	  sciatic	  nerve,	  gut,	  and	  bone	  marrow.	  Although	  they	  display	  cell	   intrinsic	  differences	  depending	  on	  the	  source	  and	   timing	  of	   isolation,	  post-­‐migratory	  NC-­‐like	   cells	   are	   capable	  of	  differentiating	   into	  several	   neural	   and	   non-­‐neural	   cell	   types.	   Therefore,	   given	   their	   broad	   developmental	  
potential	  and	  their	  accessibility	  in	  adult	  organs,	  it	  has	  been	  proposed	  that	  NC-­‐like	  cells	  might	  have	  therapeutic	  value.	  However,	  a	  major	  limitation	  for	  the	  use	  of	  post-­‐migratory	  NC-­‐like	   cells	   is	   their	   restricted	   availability	   and	   expandability	   (Dupin	   and	   Sommer,	  2012).	  	  Given	  the	  broad	  range	  of	  diseases	  with	  NC	  etiology	  and	  the	  restrictions	  in	  the	  isolation	  of	   human	   NC,	   the	   development	   of	   new	  model	   systems	   for	   the	   generation	   of	   this	   cell	  population	  is	  imperative.	  	  Such	  models	  should	  provide	  good	  platforms	  not	  only	  to	  study	  the	   mechanisms	   underlying	   NC	   self-­‐renewal	   and	   cell	   fate	   specification	   but	   also	   for	  human	  disease	  modeling.	  In	  the	  last	  decade,	  a	  major	  effort	  has	  focused	  on	  the	  derivation	  of	   NC	   cells	   from	   human	   embryonic	   stem	   cells	   (hESCs)	   and	   induced	   pluripotent	   stem	  cells	   (iPSCs).	   	   Several	   studies	  have	   reported	   the	  differentiation	  of	  NC	  derivatives	   from	  hESCs	   or	   iPSCs,	   including	   melanocytes,	   nociceptive	   neurons,	   and	   autonomic	   neurons	  (Mica	   et	   al.,	   2013;	   Lee	   et	   al.,	   2009;	   Chambers	   et	   al.,	   2012).	   For	   instance,	   Lee	   and	   co-­‐authors	   reported	   the	   derivation	   of	   patient-­‐specific	   iPSCs	   and	   their	   differentiation	   into	  various	   NC	   derivatives,	   including	   PNS	   neurons.	   The	   patients	   suffered	   from	   familial	  dysautonomia	  (FD),	  a	   rare	  PNS	  neuropathy	  caused	  by	  a	  mutation	   in	   the	   IKBAKP	  gene.	  The	  derived	  NC	  progenitors	  expressed	   low	   levels	  of	   the	   IKBAKP	  transcript,	   suggesting	  that	   the	   differentiation	   protocol	   applied	   recapitulated	   specific	   mechanisms	   of	   the	  disease.	  Kim	  and	  colleagues	  (Kim	  et	  al.,	  2014)	  now	  report	  a	  major	  advance	   in	   this	  direction	  by	  directly	   reprogramming	   human	   postnatal	   fibroblasts	   into	   iNCCs.	   In	   brief,	   the	   authors	  used	   a	   Sox10::eGFP	   reporter	   hESC	   line	   to	   determine	   which	   factors	   are	   sufficient	   to	  induce	   NC	   from	   hESC-­‐derived	   fibroblasts.	   The	   transcription	   factor	   Sox10	   is	   broadly	  expressed	  in	  undifferentiated	  NC	  cells	  during	  development	  and	  in	  adulthood	  and	  plays	  a	  crucial	  role	  in	  NC	  cell	  maintenance,	  survival,	  and	  lineage-­‐specific	  differentiation	  (Britsch	  et	  al.,	  2001).	  Therefore,	  Kim	  and	  colleagues	  postulated	  that	  Sox10	  would	  be	  required	  for	  iNCC	   induction.	   By	   using	   an	   inducible	   Sox10	   expression	   system	   they	   observed	   that	  Sox10	   overexpression	   in	   combination	   with	   extracellular	   matrix	   components	   and	  epigenetic	   modifiers	   was	   sufficient	   to	   activate	   GFP	   expression	   in	   Sox10::eGFP	  fibroblasts	   (Figure	   1).	   They	   speculated	   that	  Wnt	   signaling	  might	   further	   promote	   NC	  formation,	  since	  Wnt	  is	  one	  of	  the	  main	  morphogens	  for	  NC	  induction	  at	  the	  neural	  plate	  border	  (Groves	  and	  LaBonne,	  2014).	   Indeed,	  by	  adding	  the	  Wnt	  agonist	  Chir	  99021	  to	  the	  induction	  protocol	  they	  were	  able	  to	  increase	  the	  number	  of	  putative	  iNCCs	  (Figure	  1).	   The	   iNCCs	   displayed	  NC-­‐enriched	   gene	   signatures	   comparable	   to	   that	   observed	   in	  hESC-­‐derived	   NC	   cells	   and	   were	   able	   to	   self-­‐renew	   for	   several	   passages,	   even	   after	  withdrawal	  of	  exogenous	  Sox10.	   Interestingly,	  by	  using	  an	  Oct4::eGFP	  reporter	  system	  
Kim	   and	   co-­‐authors	   demonstrated	   that	   their	   iNCC	   reprogramming	   protocol	   does	   not	  involve	  a	  pluripotent	  intermediate	  stage.	  	  To	  apply	  their	  iNCC	  induction	  protocol	  to	  postnatal	  human	  fibroblasts	  the	  authors	  found	  that	   expression	   of	   the	   surface	   marker	   CD34	   allows	   segregation	   of	   iNCCs	   from	   non-­‐reprogrammed	   cells.	   In	   ovo	   and	   ex	   vivo	   transplantation	   assays	   in	   chicken	   embryos	  revealed	   that	   fibroblast-­‐derived	   iNCCs	   were	   able	   to	   migrate	   and	   integrate	   into	   NC-­‐derived	  tissues,	  such	  as	  the	  dorsal	  root	  and	  sympathetic	  ganglia	  and	  the	  enteric	  nervous	  system.	  	  Transplantation	   experiments	   of	   this	   kind	   leave	   open	   the	   question	   of	   whether	   the	  transplanted	   cell	   population	   is	   indeed	   composed	   of	   multipotent	   cells	   with	   stem	   cell	  features	   or	   rather	   a	   mixture	   of	   restricted	   progenitors.	   	   Likewise,	   quail-­‐chick	  transplantation	   experiments	   performed	   several	   years	   ago	   were	   fundamental	   in	  demonstrating	   that	   the	   NC	   as	   a	   population	   is	   highly	   plastic	   and	   able	   to	   respond	   to	  external	   cues	   by	   adopting	   different	   fates	   (Dupin	   and	   Sommer,	   2012).	   However,	   such	  transplantation	   experiments	   cannot	   exclude	   mosaicism	   or	   re-­‐activation	   of	   a	  multipotency	  program	  upon	  transplantation.	  The	  developmental	  potential	  of	  a	  cell	  has,	  therefore,	   to	   be	   addressed	   by	   clonal	   assays.	   Of	   note,	   the	   authors	   performed	   in	   vitro	  clonal	  experiments,	  in	  that	  single	  GFP-­‐labelled	  iNCCs	  were	  co-­‐cultured	  with	  other	  iNCCs.	  About	  60%	  of	  the	  clones	  analyzed	  were	  multifated,	  indicating	  that	  their	  protocol	  enables	  the	   generation	   of	   multipotent	   iNCCs.	   These	   findings	   are	   in	   agreement	   with	   classical	  clonal	   assays	   of	   avian	   and	   mammalian	   NC	   cells	   that	   have	   previously	   provided	  compelling	  evidence	  for	  multipotency	  in	  vitro	  (Dupin	  and	  Sommer,	  2012).	  	  The	  NC	  is	  a	  product	  of	   its	  embryonic	  environment	  and	  the	   in	  vitro	  and	  transplantation	  conditions	   most	   likely	   do	   not	   reiterate	   the	   milieu	   of	   the	   developing	   embryo.	   For	  instance,	  although	  NC	  multipotency	   in	  vitro	  has	  been	  comprehensively	  established,	   the	  question	  of	  whether	  NC	   cells	   are	   indeed	  multifated	   in	  vivo	   or	   rather	   a	  mixture	  of	  pre-­‐specified	   progenitors	   remains	   highly	   controversial.	   This	   uncertainty	   also	   raises	   the	  question	   of	   whether	   the	   iNCCs	   obtained	   in	   this	   study	   are	   actually	   equivalent	   to	   their	  endogenous	  in	  vivo	  counterparts.	  This	  point	  might	  be	  relevant	  if	  iNCCs	  shall	  be	  used	  to	  study	   mechanisms	   of	   fate	   specification	   and	   cellular	   differentiation	   or	   to	   pursue	  functional	  cell	  replacement	  strategies	  in	  the	  future.	  In	   any	   case,	   the	   iNCCs	   generated	   by	   Kim	   and	   co-­‐authors	   constitute	   a	   very	   valuable	  platform	  for	  the	  detection	  of	  new	  mechanisms	  underlying	  NC-­‐related	  diseases.	   Indeed,	  in	  this	  study	  the	  authors	  not	  only	  showed	  that	  FD-­‐patient	  iNCCs	  displayed	  low	  levels	  of	  the	   IKBAKP	   transcript	  most	   likely	  due	   to	  alternative	   splicing,	  but	  also	   identified	  novel	  splicing	  variants	  in	  two	  core	  NC	  transcription	  factors	  (Figure	  1).	  It	  will	  be	  interesting	  to	  
use	  iNCCs	  in	  large-­‐scale	  drug	  screenings	  to	  identify	  new	  molecules	  capable	  of	  reversing	  the	  phenotype	  of	  this	  and	  other	  diseases.	  Thus,	  iNCCs	  hold	  great	  potential	  for	  cell-­‐based	  therapies.	   To	   realize	   this	   potential,	   however,	   the	   genomic	   integration	   of	   retrovirally	  transduced	   Sox10	  must	   be	   circumvented,	   for	   instance	   with	   chemical	   reprogramming.	  Additionally,	   it	   is	   crucial	   that	   the	   functionality	   of	   newly	   generated	   cell	   types	   will	   be	  validated	  in	  in	  vivo	  disease	  models.	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Figure	  Legends	  
Figure	  1.	  Direct	  reprogramming	  of	  fibroblasts	  into	  iNCCs	  and	  their	  application	  in	  
disease	  modeling.	  	  Fibroblasts	  can	  be	  reprogrammed	  into	  iNCCs	  by	  transient	  Sox10	  overexpression	  and	  a	  combination	   of	   extracellular	   matrix	   (ECM)	   components,	   epigenetic	   modifiers	   and	   the	  Wnt	  agonist	  Chir99021.	  iNCCs	  express	  	  CD34	  and	  can	  be	  differentiated	  into	  various	  NC	  derivatives	  (Left	  side).	  	  This	  approach	  represents	  an	  excellent	  platform	  for	  the	  modeling	  of	   NC-­‐related	   diseases.	   Indeed,	   application	   of	   this	   induction	   protocol	   to	   familial	  dysautonomia	  (FD)	  fibroblasts	  revealed	  that	   iNCCs	  derived	  from	  FD	  patients	  displayed	  aberrant	   splicing	   variants	   of	   IKBKAP,	   PAX3	   and	   MEF2c	   transcripts	   (Right	   side).	  
Abbreviations:	  hESCs	  (human	  embryonic	  stem	  cells);	  iNCCs	  (induced	  neural	  crest	  cells);	  5-­‐AZA	  (5-­‐aza-­‐2’deoxycytidine);	  VPA	  (valproic	  acid);	  PNS	  (peripheral	  nervous	  system).	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